z-logo
open-access-imgOpen Access
A novel human S10F‐Hsp20 mutation induces lethal peripartum cardiomyopathy
Author(s) -
Liu GuanSheng,
Gardner George,
Adly George,
Jiang Min,
Cai WenFeng,
Lam Chi Keung,
Alogaili Fawzi,
Robbins Nathan,
Rubinstein Jack,
Kranias Evangelia G.
Publication year - 2018
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.13665
Subject(s) - peripartum cardiomyopathy , ejection fraction , medicine , heart failure , autophagy , cardiomyopathy , cardiology , apoptosis , cardiac function curve , endocrinology , biology , genetics
Heat shock protein 20 (Hsp20) has been shown to be a critical regulator of cardiomyocyte survival upon cardiac stress. In this study, we investigated the functional significance of a novel human Hsp20 mutation (S10F) in peripartum cardiomyopathy. Previous findings showed that cardiac‐specific overexpression of this mutant were associated with reduced autophagy, left ventricular dysfunction and early death in male mice. However, this study indicates that females have normal function with no alterations in autophagy but died within a week after 1‐4 pregnancies. Further examination of mutant females revealed left ventricular chamber dilation and hypertrophic remodelling. Echocardiography demonstrated increases in left ventricular end‐systolic volume and left ventricular end‐diastolic volume, while ejection fraction and fractional shortening were depressed following pregnancy. Subsequent studies revealed that cardiomyocyte apoptosis was elevated in mutant female hearts after the third delivery, associated with decreases in the levels of Bcl‐2/Bax and Akt phosphorylation. These results indicate that the human S10F mutant is associated with dysregulation of cell survival signalling, accelerated heart failure and early death post‐partum.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here